Form 4: Allakos Inc. Director Andreatta Reports Cancellation of Stock Options Following Merger Agreement
SEC Form 4 Filing
Director Robert E. Andreatta reports the cancellation of several stock options related to the Allakos Inc. merger with Concentra Biosciences, LLC.
Summary
- Robert E. Andreatta, a director of Allakos Inc., filed a Form 4 detailing changes in beneficial ownership.
- The report indicates the cancellation of multiple stock options on May 15, 2025, due to the merger agreement between Allakos Inc., Concentra Biosciences, LLC, and Concentra Merger Sub III, Inc. dated April 1, 2025.
- The cancelled options had various exercise prices and expiration dates, covering a total of 335,352 shares of common stock.
- Following the reported transactions, Andreatta's derivative security holdings are zero.
Sentiment
Score: 5
Explanation: The document is neutral, reporting a procedural outcome of a merger agreement. It doesn't inherently convey positive or negative sentiment.
Future Outlook
The document does not contain any forward-looking statements beyond the implications of the merger agreement.
Industry Context
This filing reflects the impact of mergers and acquisitions on executive compensation, specifically the cancellation of stock options as part of the deal's terms. This is a common occurrence in corporate mergers.
Stakeholder Impact
- Shareholders may be impacted by the merger, which triggered the cancellation of these options.
Key Dates
| Date | Description |
|---|---|
| April 1, 2025 | Date of the Agreement and Plan of Merger between Allakos Inc., Concentra Biosciences, LLC, and Concentra Merger Sub III, Inc. |
| May 15, 2025 | Date of the transaction (cancellation of stock options). |
| May 24, 2034 | Latest expiration date of the cancelled stock options. |
Keywords
Form 4, Allakos Inc., Robert E. Andreatta, Stock Options, Cancellation, Merger, Concentra Biosciences
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.